Brevan Howard Capital Management LP Has $2.72 Million Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Brevan Howard Capital Management LP boosted its position in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 53.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,220 shares of the medical instruments supplier's stock after acquiring an additional 771 shares during the quarter. Brevan Howard Capital Management LP's holdings in Mettler-Toledo International were worth $2,717,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in MTD. Norges Bank acquired a new stake in Mettler-Toledo International during the fourth quarter valued at approximately $372,954,000. Proficio Capital Partners LLC bought a new stake in Mettler-Toledo International in the fourth quarter worth about $163,216,000. T. Rowe Price Investment Management Inc. raised its holdings in Mettler-Toledo International by 36.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock worth $444,327,000 after buying an additional 96,300 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Mettler-Toledo International by 53.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 214,281 shares of the medical instruments supplier's stock valued at $262,211,000 after purchasing an additional 74,187 shares in the last quarter. Finally, Seilern Investment Management Ltd acquired a new position in shares of Mettler-Toledo International in the 4th quarter valued at about $89,221,000. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Activity at Mettler-Toledo International

In other news, insider Gerry Keller sold 600 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now directly owns 6 shares of the company's stock, valued at $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company's stock, valued at $964,248.46. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Stock Down 2.0 %

NYSE:MTD traded down $21.67 during trading hours on Friday, hitting $1,079.96. 133,782 shares of the stock were exchanged, compared to its average volume of 145,671. Mettler-Toledo International Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The company has a market capitalization of $22.44 billion, a P/E ratio of 26.65, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40. The company's 50 day moving average is $1,118.64 and its two-hundred day moving average is $1,222.96.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. The company had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $8.89 EPS. On average, equities research analysts expect that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MTD. Evercore ISI upped their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research report on Monday, February 10th. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price objective for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Wells Fargo & Company boosted their target price on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. StockNews.com downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Finally, Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a research report on Monday, April 7th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of "Hold" and an average target price of $1,296.13.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.